Skip to content

Benjamin Oritsemuelebi

2 papers in the library · publishing 2024-2026

Papers

Sort Most recent Most cited

Antipsychotic-like Effects of Jobelyn® in Ketamine-induced Psychosis in Mice

Emerging Frontiers in Translational Biomedicine and Health Sciences July 10, 2026 Adrian Itivere Omogbiya, Benneth Ben-Azu, Maxwell Oboh et al.

Background: Jobelyn® (JB) is a polyherbal formulation with proven benefits on psychosis, a psychiatric disorder, validated in dopamine-agonist models. However, its effect in ketamine, a glutamate antagonist, is linked to schizophrenia's pathology due to N-methyl-D-aspartate (NMDA) receptor hypofunction, which remains largely unknown. Hence, this study investigates the antipsychotic effectsof JB...

Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission

IBRO Neuroscience Reports January 3, 2024 Benneth Ben-Azu, Olusegun G Adebayo, Aliance R Fokoua et al.

A decrease in the levels of antioxidant arsenals exacerbate generation of reactive oxygen/nitrogen species, leading to neurochemical dysfunction, with significant impact on the pathogenesis of psychotic disorders such as schizophrenia. This study examined the preventive and reversal effects of diosgenin, a phyto-steroidal saponin with antioxidant functions in mice treated with ketamine which...